Patented drug therapy for lung condition has been exclusively optioned to Theratome Bio March 4, 2019
Esanex Announces Successful End-of-Phase 2 Meeting for SNX-5422 in Neuroendocrine Tumor October 4, 2018
IU physician-entrepreneur seeks to decrease unnecessary transfers from nursing homes to hospitals October 3, 2018
Apexian Chief Scientific Officer Awarded $2.3 Million National Cancer Institute Grant September 26, 2018
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares July 16, 2018
Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology May 21, 2018
